Christelle De La Fouchardiere

机构：Centre Léon Bérard, Institut Paoli-Calmettes

发表论文 5 篇 · 总被引 28 次 · h-index 2

代表论文

• Final analysis of the randomized phase 2 part of the ASPEN-06 study: A phase 2/3 study of evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with HER2-overexpressing gastric/gastroesophageal cancer (GC). (2025 · Journal of Clinical Oncology · 被引 16)
• Trastuzumab deruxtecan (T-DXd) vs ramucirumab (RAM) + paclitaxel (PTX) in second-line treatment of patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) unresectable/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary analysis of the randomized, phase 3 DESTINY-Gastric04 study. (2025 · Journal of Clinical Oncology · 被引 10)
• POD1UM-303/INTERAACT2 subgroup analyses and impact of delayed retifanlimab treatment on outcomes in patients with squamous cell carcinoma of the anal canal (SCAC). (2025 · Journal of Clinical Oncology · 被引 1)
• Assessment of pathologic response in the colorectal cancer cohort of the IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors. (2025 · Journal of Clinical Oncology · 被引 1)
• SMAD4 gene mutation and prognosis of pancreatic adenocarcinoma. (2013 · Journal of Clinical Oncology)